NEURO-SYS

Discover NEURO-SYS: Your Expert Partner in Neuropharmacology.   Our Mission: To provide highly personalized preclinical study solutions for our clients in the pharmaceutical and biotechnology industries.   Our Focus: - Reliable, well-validated in vitro and in vivo neurodegenerative disease models. - Custom pharmacological safety and efficacy studies. - Our clients’ needs! At NEURO-SYS, our expertise in and focus on neuropharmacology allows us to deliver specialized attention to each client, providing tailored study designs, consultative direction, and detailed study reports. These efforts help our clients move to the next phase of the discovery pipeline with greater efficiency! What also sets Neuro-Sys apart is its pioneering spirit, driving continuous innovation that others seek to emulate. Now, with our newly expanded facilities and growing team, we can perform even more studies and research programs. Our strategic expansion enhances our ability to manage large-scale projects and provides even more comprehensive solutions for our partners.   Choose NEURO-SYS as your partner for custom pharmacological studies and expertise in neuroscience. NEURO-SYS, Your R&D Department! www.neuro-sys.com #Neuropharmacology #NeurodegenerativeDiseases #PreclinicalResearch #DrugDiscovery #Alzheimers #Parkinsons #ALS

🚀 Neuro-Sys Takes Flight: Unveiling Our Cutting-Edge Research Hub We are thrilled to announce a transformative milestone in Neuro-Sys' journey! We've moved into our new state-of-the-art facility, spanning an impressive 2,000 m² (approx. 20,000 sq ft). This expansion marks a quantum leap in our capabilities to drive innovation in neurodegenerative research.   Key highlights of our expansion: • 4x larger space, enabling simultaneous complex studies • A talented, specialized team of 40+ experts • Massive investment in cutting-edge equipment • Enhanced capacity for more robust and relevant studies This move empowers us to deliver even more powerful, pertinent, and reliable studies to our valued clients in the pharmaceutical, biotech, and academic sectors. We're excited to push the boundaries of neurodegenerative research further than ever before. Stay tuned for more updates as we embark on this thrilling new chapter!   #NeurodegenerativeResearch #Innovation #Expansion #CuttingEdgeScience

Now happening at Society for Neuroscience, Chicago! Noelle Callizot presenting our new poster "Lecanemab induces phenotypic change in glial and microglial cells in Alzheimer's disease models: vitro and vivo evidences." Poster C10, Booth 535

Now happening at Society for Neuroscience, Chicago! Alexandre Henriques presenting our new poster "Impaired proteasome activity and autophagy-lysosome pathway in in vitro models of amyotrophic lateral sclerosis." Poster C62, Booth 535

A Better Work Environment for Our Team! At Neuro-Sys, we believe that a comfortable and cutting-edge workspace boosts productivity and creativity. Our new facilities offer modern amenities and collaborative spaces, ensuring that our team thrives while they are conducting groundbreaking research on neurodegenerative diseases. Exciting times ahead for our talented professionals! #EmployeeWellbeing #TeamSuccess

🔬 A new era begins for our clients! With our expansive new facilities, we’re ready to undertake more projects and manage larger, more complex studies. Are you ready to experience the benefits of even higher-quality studies? Drop us a message to get started! #NeuroscienceResearch #Innovation

🚀 Big news at NEURO-SYS! We are thrilled to announce that we are moving to new labs, 4 times larger! This will allow us to welcome new talent and increase capacity to conduct neurodegenerative diseases studies. Stay tuned for more details! #Neuro-Sys #Expansion #Neuroscience 

#SfN24 is just around the corner, and NEURO-SYS will be there showcasing our latest scientific innovations! Come by booth 535 to connect, collaborate, and explore our newest in vitro and in vivo models and research services. And, don't miss the chance to catch one of our posters showcasing our latest findings in Alzheimer's Disease and ALS.    PSTR332.06/C62  Tuesday, 10/8/24 1:00pm Impaired proteasome activity and autophagy-lysosome pathway exacerbates motor neuron loss and TDP43 proteinopathy in in vitro models of Amyotrophic Lateral Sclerosis.   PSTR389.22/C10 Wednesday, 10/9/24 8:00am Glial and microglial phenotypic changes after treatment with Lecanemab: vitro and vivo evidences.

Congratulations to Sasha Milton from University of California, San Francisco who scored Phillies vs. Yankees tickets as part of NEURO-SYS’ #AAIC24 giveaway! We hope that you enjoy the game and have an unforgettable experience at Citizens Bank Park. Special thanks to everyone who participated and helped make our giveaway a success. Stay tuned for more exciting events and opportunities from NEURO-SYS (we hear our #SFN giveaway is 🔥).

Presentation day at #AAIC24! Drop by poster # 829 and chat with our CSO, Noelle Callizot on our findings "Lecanemab induces phenotypic change in glial and microglial cells in Alzheimer’s disease models: vitro and vivo evidences." See you there!